Viewing Study NCT04612192


Ignite Creation Date: 2025-12-24 @ 3:17 PM
Ignite Modification Date: 2026-01-05 @ 5:14 PM
Study NCT ID: NCT04612192
Status: COMPLETED
Last Update Posted: 2025-03-12
First Post: 2019-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Light Therapy for Chronic Insomnia in General Practice
Sponsor: University Hospital, Strasbourg, France
Organization:

Study Overview

Official Title: Light Therapy for Chronic Insomnia in General Practice: a Randomized Double Blind Study
Status: COMPLETED
Status Verified Date: 2025-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Insolux
Brief Summary: * Sleep disorders, especially insomnia
* Attention deficits (or disorders), daytime somnolence and drug dependence
* The goal is to evaluate whether light therapy could be used as an efficient alternative treatment with direct application in general practice
Detailed Description: Insomnia affects 15 to 20% of the general French adult population and increases with age. General practitioners (GPs) are the first confronted to sleep disorders, especially insomnia.

Cognitive-behavioral therapies (CBT) have proven effective, but their implementation in everyday practice is limited, and alternative treatments are still needed.

Light not only has a great influence on the sleep-wake cycle and alertness, but also on mood and cognitive functions.

The administration time of light condition will be calculated for each individual in a modality that has no impact on the circadian phase.

Study will be conduct on an outpatient basis in general practice

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: